Company / Free Cash Flow
Repligen Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$93.9M
FY2025
5-year range
$51.9M / $149.7M
FY2021-FY2025
Trend
-37.3%
vs FY2024
Sector context
#47 of 194
Health Care
What the data says
Repligen's free cash flow of $94M is higher than 76% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from $3M in FY2016 to $150M in FY2024.
Based on SEC 10-K filings.
$94M in FY2025 with a 5-year CAGR of +18.5%. Top quartile in the Health Care sector.
Improved from $78M to $94M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 194This company $93.9M Sector average $470.8M
▼
-80.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.5%, indicating consistent growth.
- In FY2025, free cash flow decreased 37.3% year-over-year.
- Ranks #47 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $93.9M | -37.3% |
| FY2024 | $149.7M | +92.7% |
| FY2023 | $77.7M | -10.9% |
| FY2022 | $87.2M | +68.0% |
| FY2021 | $51.9M | +29.3% |
| FY2020 | $40.2M | -17.5% |
| FY2019 | $48.7M | +120.1% |
| FY2018 | $22.1M | +84.5% |
| FY2017 | $12.0M | +275.4% |
| FY2016 | $3.2M | -85.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026